In the systemic DLBCL study, the activated PI3K‐mTOR axis was associated with poor prognosis in the CHOP‐treated group but not in the R‐CHOP‐treated group.34 This evidence concerns the gene DDIT3 and diffuse large B-cell lymphoma.